These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14978191)

  • 1. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.
    Kobayashi M; Saitoh H; Kobayashi M; Tadano K; Takahashi Y; Hirano T
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1029-35. PubMed ID: 14978191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.
    Hesselink DA; van Hest RM; Mathot RA; Bonthuis F; Weimar W; de Bruin RW; van Gelder T
    Am J Transplant; 2005 May; 5(5):987-94. PubMed ID: 15816878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.
    El-Sheikh AA; Koenderink JB; Wouterse AC; van den Broek PH; Verweij VG; Masereeuw R; Russel FG
    Transl Res; 2014 Jul; 164(1):46-56. PubMed ID: 24486136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
    Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine.
    Westley IS; Brogan LR; Morris RG; Evans AM; Sallustio BC
    Drug Metab Dispos; 2006 Feb; 34(2):261-6. PubMed ID: 16272406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats.
    Kwon MH; Yoon JN; Baek YJ; Kim YC; Cho YY; Kang HE
    Biopharm Drug Dispos; 2016 Sep; 37(6):352-65. PubMed ID: 27241939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.
    Saitoh H; Kobayashi M; Oda M; Nakasato K; Kobayashi M; Tadano K
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):406-13. PubMed ID: 17072094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
    Morissette P; Albert C; Busque S; St-Louis G; Vinet B
    Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.
    Matsunaga N; Suzuki K; Nakanishi T; Ogawa M; Imawaka H; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):142-8. PubMed ID: 25989889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus.
    Patel CG; Ogasawara K; Akhlaghi F
    Xenobiotica; 2013 Mar; 43(3):229-35. PubMed ID: 22934787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.
    Heller T; van Gelder T; Budde K; de Fijter JW; Kuypers D; Arns W; Schmidt J; Rostaing L; Powis SH; Claesson K; Macphee IA; Pohanka E; Engelmayer J; Brandhorst G; Oellerich M; Armstrong VW
    Am J Transplant; 2007 Jul; 7(7):1822-31. PubMed ID: 17532750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
    Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
    Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
    Brown NW; Aw MM; Mieli-Vergani G; Dhawan A; Tredger JM
    Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
    Kuypers DR; Vanrenterghem Y; Squifflet JP; Mourad M; Abramowicz D; Oellerich M; Armstrong V; Shipkova M; Daems J
    Ther Drug Monit; 2003 Oct; 25(5):609-22. PubMed ID: 14508385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
    Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
    Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.
    Naesens M; Kuypers DR; Verbeke K; Vanrenterghem Y
    Transplantation; 2006 Oct; 82(8):1074-84. PubMed ID: 17060857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.